CORC

在结果中检索

CORC

浏览/检索结果: 共42条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Concomitant SBRT and EGFR-TKI Versus EGFR-TKI Alone for Oligometastatic NSCLC: A Multicenter, Randomized Phase II Study 会议论文
作者:  Peng, P.;  Chen, Y.;  Han, G.;  Meng, R.;  Zhang, S.
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy 会议论文
作者:  Ma, Y.;  Wu, D.;  Liu, J.;  Mu, Z.;  Liu, L.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy 会议论文
作者:  Wu, D.;  Liu, J.;  Mu, Z.;  Liu, L.;  Li, K.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Dynamic ctDNA Monitoring Revealed Novel Resistance Mechanisms and Response Predictors of Osimertinib Treatment in East Asian NSCLC Patients 会议论文
作者:  Chang, J.;  Hu, Z.;  Ji, D.;  Chuai, S.;  Shen, W.
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS stud 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Zhou, Q.;  Zhang, H.;  Jiang, L.;  Shi, Y.;  Chen, Y.
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Upfront Radiation Therapy with TKI Improved the Intracranial PFS but Not OS in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases 会议论文
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01
作者:  Wang, C.;  Lu, X.;  Zhou, Z.;  Bi, N.;  Wang, J.
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Role of Enhanced Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment 会议论文
BLOOD, 2018-11-29
作者:  Qiu, Shaowei;  Paterson, Andrew J.;  Abraham, Ajay;  He, Jianbo;  Shah, Mansi
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Genome-Wide Screen of DNA Methylation Changes Reveals GABBR2 as a Novel Potential Target for EGFR 19 Deletion Adenocarcinoma with Erlotinib 会议论文
作者:  Liu, Fatao;  Zhou, Yi;  Zhou, Zhen;  Liu, Yun;  Chen, Zhiwei
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naive Patients with EGFRm plus NSCLC: An Interim Analysis 会议论文
作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
afatinib  EGFR  NSCLC  
A Phase I Dose Expansion Study of Epitinib to Evaluate Efficacy and Safety in EGFR Mutation Positive (EGFRm plus ) NSCLC Patients with Brain Metastasis 会议论文
作者:  Zhou, Qing;  Gan, Bin;  Hong, Qunying;  Wang, Mengzhao;  Liu, Xiaoqing
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace